Health ❯Healthcare ❯Neurology

Cognitive Disorders

Dementia Alzheimer's Disease Parkinson's Disease Mild Cognitive Impairment Amyloid Plaques in Alzheimer's Dementia Risk Factors Memory Loss Memory Disorders Alzheimer's Detection All-cause Dementia Dementia Management Schizophrenia Alzheimer's Disease Treatments

EMA Recommends Donanemab for Early Alzheimer’s in the EU

The recommendation imposes MRI screening to rule out vascular narrowing, capping eligibility at one copy of the ApoE4 gene.

Frequent Gabapentin Prescriptions Tied to Increased Dementia and Cognitive Impairment Risk

Parkinson’s Onset Side Predicts Divergent Cognitive and Mental Health Trajectories

FDA Approves 95% Sensitive Blood Test for Alzheimer’s

FDA Approves First Blood Test for Alzheimer’s Diagnosis

FDA Approves First Blood Test for Early Alzheimer’s Diagnosis in Symptomatic Adults

FDA Approves First Blood Test for Alzheimer’s Diagnosis

Leqembi Approved by European Regulators for Early-Stage Alzheimer's Treatment

New Study Links Diabetes Drug Class to 45% Lower Dementia Risk

GLP-1 Drugs Like Ozempic Linked to Lower Dementia Risk in New Studies

House Republicans to Investigate Alleged Cover-Up of Biden’s Cognitive Decline

EU Drug Agency Recommends Approval of First Alzheimer’s Treatment Targeting Disease Progression

Study Links Common Medications to Reduced Dementia Risk

EMA Approves Lecanemab for Early-Stage Alzheimer’s Treatment in EU

New Alzheimer's Drugs Face Scrutiny Over Efficacy and Safety

GLP-1 Drug Shows Promise in Slowing Alzheimer's Cognitive Decline

New Blood Tests Enhance Alzheimer's Diagnosis Accuracy